Atossa Therapeutics Inc (ATOS)

07:45 AM

Atossa Genetics stock holds Buy rating at H.C. Wainwright on FDA feedback - Investing.com

07:45 AM

Dec 04, 2025

Will Atossa Therapeutics Inc. stock outperform tech sector in 2025July 2025 Recap & Safe Capital Investment Plans - Newser

Dec 04, 2025

Dec 04, 2025

Is Atossa Therapeutics Inc. (YAG2) stock a buy before new product rolloutQuarterly Portfolio Report & Fast Momentum Entry Tips - Newser

Dec 04, 2025

Dec 04, 2025

Atossa Completes FDA Meeting on Regulatory Strategies - TipRanks

Dec 04, 2025

Dec 04, 2025

Atossa Therapeutics Completes FDA Meeting on (Z)-Endoxifen Strategy - TradingView

Dec 04, 2025

Dec 04, 2025

Atossa Therapeutics Details Accelerated FDA Strategy to Advance (Z)-Endoxifen Across Breast Cancer Continuum - PR Newswire

Dec 04, 2025

Dec 04, 2025

Atossa Genetics Inc. (NASDAQ:ATOS) Given Average Rating of "Hold" by Analysts - MarketBeat

Dec 04, 2025

Dec 04, 2025

Is Atossa Therapeutics Inc. (YAG2) stock considered safe havenJuly 2025 Intraday Action & AI Driven Stock Movement Reports - Newser

Dec 04, 2025

Dec 04, 2025

Is Atossa Therapeutics Inc. stock undervalued vs historical averagesJuly 2025 Big Picture & Step-by-Step Swing Trade Plans - Newser

Dec 04, 2025

Dec 04, 2025

Is Atossa Therapeutics Inc. (YAG2) stock good for long term investingWeekly Investment Summary & Low Risk Entry Point Guides - Newser

Dec 04, 2025

Dec 03, 2025

Adversity is less terrifying than hope: Atossa Therapeutics Inc (ATOS) - Setenews

Dec 03, 2025

Dec 03, 2025

Will Atossa Therapeutics Inc. stock beat EPS estimates2025 Key Highlights & High Return Stock Watch Alerts - Newser

Dec 03, 2025

Dec 03, 2025

How Atossa Therapeutics Inc. (YAG2) stock performs in easing cyclesWeekly Trend Summary & Risk Controlled Stock Pick Alerts - Newser

Dec 03, 2025

Dec 02, 2025

S P Trends: How buybacks impact ARMOUR Residential REIT Inc stock valuePrice Action & Daily Profit Maximizing Trade Tips - BỘ NỘI VỤ

Dec 02, 2025

Dec 02, 2025

Atossa Therapeutics (ATOS) Advances Glioblastoma Research with A - GuruFocus

Dec 02, 2025

Dec 02, 2025

Insilico Medicine and Atossa Therapeutics Publish AI-Driven Study in Nature Scientific Reports Identifying (Z)-Endoxifen as a Potential Therapeutic Candidate for Glioblastoma - PR Newswire

Dec 02, 2025

Dec 02, 2025

Can Atossa Therapeutics Inc. (YAG2) stock surprise with quarterly results2025 Momentum Check & Fast Gain Stock Tips - Newser

Dec 02, 2025

Dec 02, 2025

Published on: 2025-12-02 04:01:13 - Newser

Dec 02, 2025

Dec 02, 2025

Will Atossa Therapeutics Inc. (YAG2) stock hit Wall Street targetsOptions Play & Precise Trade Entry Recommendations - Newser

Dec 02, 2025

Nov 30, 2025

Will Atossa Therapeutics Inc. stock outperform international peersJuly 2025 Levels & Fast Moving Market Watchlists - BỘ NỘI VỤ

Nov 30, 2025

Nov 28, 2025

Is Atossa Therapeutics Inc (ATOS) positioned for future growth? - Setenews

Nov 28, 2025

Nov 27, 2025

Is Atossa Therapeutics Inc. stock a buy before product launches2025 Major Catalysts & Verified Momentum Watchlists - BỘ NỘI VỤ

Nov 27, 2025

Nov 27, 2025

Atossa Therapeutics Selects PSI as Contract Research Organization for Pivotal Dose-Ranging Study of (Z)-Endoxifen in Metastatic Breast Cancer (PR Newswire) - Aktiellt

Nov 27, 2025

Nov 26, 2025

Atossa Therapeutics, Inc. (ATOS) 5.16% in After-hours: What’s Driving the Move? - Stocks Telegraph

Nov 26, 2025

Nov 26, 2025

Atossa Therapeutics Announces Positive FDA Feedback, Advances Toward IND for (Z)-Endoxifen Clinical Program in ER+/HER2- Metastatic Breast Cancer (PR Newswire) - Aktiellt

Nov 26, 2025

Nov 21, 2025

Why Atossa Therapeutics Inc. (YAG2) stock is listed among top recommendationsRecession Risk & Verified High Yield Trade Plans - newser.com

Nov 21, 2025

Nov 20, 2025

Is Atossa Therapeutics Inc a good long term investmentTop Performing Stocks & Free Extraordinary Earning Power - earlytimes.in

Nov 20, 2025

Nov 20, 2025

How buybacks impact Atossa Therapeutics Inc. stock value2025 Momentum Check & Safe Investment Capital Preservation Plans - newser.com

Nov 20, 2025

Nov 20, 2025

Will Atossa Therapeutics Inc. (YAG2) stock profit from AI boomWeekly Profit Report & Fast Gaining Stock Reports - newser.com

Nov 20, 2025

Nov 20, 2025

Will Atossa Therapeutics Inc. (YAG2) stock remain on Wall Street radarWeekly Investment Report & Verified Short-Term Trading Plans - newser.com

Nov 20, 2025

Nov 20, 2025

How Atossa Therapeutics Inc. stock valuations compare to rivalsPortfolio Risk Summary & Free Technical Pattern Based Buy Signals - newser.com

Nov 20, 2025

Nov 19, 2025

How rising interest rates impact Atossa Therapeutics Inc. stockMarket Performance Recap & Technical Confirmation Trade Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Published on: 2025-11-19 18:15:24 - newser.com

Nov 19, 2025

Nov 19, 2025

Published on: 2025-11-19 15:47:35 - newser.com

Nov 19, 2025

Nov 19, 2025

Is a relief rally coming for Atossa Therapeutics Inc. holdersJuly 2025 Sector Moves & AI Enhanced Trading Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Can Atossa Therapeutics Inc. (YAG2) stock deliver consistent EPS growthLayoff News & Real-Time Volume Analysis Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Does Atossa Therapeutics Inc. fit your quant trading modelWeekly Profit Recap & Weekly Watchlist of Top Performers - newser.com

Nov 19, 2025

Nov 19, 2025

Is Atossa Therapeutics Inc. reversing from oversold territoryJuly 2025 Sentiment & Stock Portfolio Risk Management - newser.com

Nov 19, 2025

Nov 19, 2025

Published on: 2025-11-19 03:34:37 - newser.com

Nov 19, 2025

Nov 19, 2025

What insider trading reveals about Atossa Therapeutics Inc. stockPortfolio Value Summary & Accurate Buy Signal Alerts - newser.com

Nov 19, 2025